Antares Pharma Reports First Quarter 2021 Financial and Operating Results
May 06, 2021 07:00 ET
|
Antares Pharma, Inc.
Increased Revenue 27% Year-Over-Year to $42.1 Million Increased Net Income to $3.8 Million, or $0.02 Per Basic and Diluted Earnings Per Share EWING, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- Antares...
Sigilon Therapeutics to Present at the BofA Securities 2021 Healthcare Conference
May 06, 2021 07:00 ET
|
Sigilon Therapeutics, Inc.
CAMBRIDGE, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded...
Belo Sun Announces Trading on the OTCQX Under Symbol “BSXGF”
May 06, 2021 07:00 ET
|
Belo Sun Mining Corp.
TORONTO, May 06, 2021 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX:BSX OTCQX:BSXGF) is pleased to announce that its common shares are now trading on the OTCQX Best...
Thunder Mountain Gold Reports on an Updated Mineral Resource Estimate that Substantially Increased the Mineral Resource at its South Mountain Project
May 06, 2021 07:00 ET
|
Thunder Mountain Gold Inc.
BOISE, Idaho and VANCOUVER, British Columbia, May 06, 2021 (GLOBE NEWSWIRE) -- Thunder Mountain Gold, Inc. (OTCQB: THMG; TSX-V: THM), (the “Company” or “THMG”) is pleased to report an updated...
BioCryst Reports First Quarter 2021 Financial Results and Upcoming Key Milestones
May 06, 2021 07:00 ET
|
BioCryst Pharmaceuticals, Inc.
—Q1 2021 ORLADEYO™ (berotralstat) net revenue of $10.9 million— —ORLADEYO now approved in U.S., Japan and EU— —BioCryst reaches agreement with FDA that change from baseline in hemoglobin is the...
Trevena Reports First Quarter 2021 Results
May 06, 2021 07:00 ET
|
Trevena Inc.
-- Company reaffirms YE target of 100 formulary approvals for OLINVYK® Announces new OLINVYK clinical outcomes study to further examine potential benefit on respiratory, GI, and...
GDS to Report First Quarter 2021 Financial Results After the Close of the U.S. Market on May 19, 2021
May 06, 2021 07:00 ET
|
GDS Holdings Limited
SHANGHAI, China, May 06, 2021 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings,” “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data...
Aravive Reports First Quarter 2021 Financial Results and Announces Plans to Investigate AVB-500 in Clinical Trial as First-Line Treatment for Pancreatic Cancer
May 06, 2021 07:00 ET
|
Aravive, Inc.
Aravive continues to expand development of AVB-500 in multiple indications and combination treatments with first-line treatment for pancreatic cancerFirst patient dosed in registrational Phase 3 trial...
Autolus Therapeutics Reports First Quarter 2021 Financial Results and Operational Progress
May 06, 2021 07:00 ET
|
Autolus Therapeutics plc
LONDON, May 06, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...
Global Health Information Exchange Market Is Expected to Reach USD 2564.79 Million by 2028 : Fior Markets
May 06, 2021 07:00 ET
|
Fior Markets
Newark, NJ, May 06, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global health information exchange market is expected to grow from USD1137.29 million in 2020 to USD...
- May 25, 2024 09:40 ET Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
- May 24, 2024 20:18 ET Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Biogen Inc. (BIIB)